DHHS/NIH/NIDA Intramural Research Program, Molecular Neuropsychiatry Research Branch, 251 Bayview Boulevard, Baltimore, MD 21224, USA.
J Addict Dis. 2009 Oct;28(4):309-19. doi: 10.1080/10550880903182960.
There is a need to bridge the gap between the fields of addiction psychiatry and general psychiatry to effectively treat co-morbid substance abuse and psychiatric disorders. This alarming epidemic transcends communities and severely impacts healthcare worldwide, yielding poor treatment outcomes and prognoses for afflicted patients. Because substance abuse can exacerbate or trigger psychosis and mood disorders, it is important to keep these issues in the forefront when evaluating patients. To address some of the complications stemming from not enough interactions between various groups of practitioners, this review addresses the neurobehavioral effects of cannabis use and their impact on patients who suffer from psychotic or affective disorders. The hope is that this article will serve as a spring board for further discussions among practitioners who treat these patients. Greater interactions between caretakers are bound to impact the care of our patients in a very positive way.
需要弥合成瘾精神病学和普通精神病学之间的差距，以有效地治疗共病物质滥用和精神障碍。这种令人震惊的流行病跨越社区，严重影响全球的医疗保健，导致患病患者的治疗结果和预后不佳。由于物质滥用会加重或引发精神病和情绪障碍，因此在评估患者时，重要的是要将这些问题放在首位。为了解决由于不同实践群体之间缺乏足够的互动而导致的一些并发症，本综述探讨了大麻使用的神经行为影响及其对患有精神病或情感障碍的患者的影响。希望本文能成为治疗这些患者的从业者进一步讨论的起点。护理人员之间更多的互动必将以非常积极的方式影响我们患者的护理。
